The efficacy and safety of fixed-dose combinations of amlodipine and atorvastatin in the treatment of patients with concomitant hypertension and dyslipidemia

被引:0
|
作者
Preston, RA
Harvey, P
Herfert, O
Dykstra, G
机构
[1] Univ Miami, Sch Med, Dept Med, Dept Clin Pharmacol, Miami, FL USA
[2] Univ Miami, Sch Med, Dept Med, Clin Res Ctr, Miami, FL USA
[3] Crouch Oak Family Practice, Addlestone, Surrey, England
[4] Linzer Str Gen Practice, Stuttgart, Germany
[5] Bluestien Cardiol, Bartlesville, OK USA
关键词
cardiovascular risk; blood pressure and cholesterol goal; attainment;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
P413
引用
收藏
页码:185A / 185A
页数:1
相关论文
共 50 条
  • [21] EFFICACY AND SAFETY OF A SINGLE-PILL COMBINATION OF ATORVASTATIN/AMLODIPINE IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
    Naydenov, Stefan Naydenov
    Runev, Nikolay Margaritov
    Manov, Emil Ivanov
    Torbova-Gigova, Svetla Georgieva
    ACTA CLINICA CROATICA, 2018, 57 (03) : 464 - 472
  • [22] EFFICACY, SAFETY AND TOLERABILITY OF A FIXED DOSE COMBINATION OF TELMISARTAN plus ATORVASTATIN IN ADULT INDIAN PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
    Sharma, A.
    Vithiavathi, S.
    Mylaswamy, M.
    Shrikanth, T.
    Ramana, K. Satish
    Bolmall, C.
    Baliga, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [23] An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension
    Luccioni, R
    Sever, PS
    DiPerri, T
    Redon, J
    Laurandin, I
    Brault, Y
    Chastang, C
    Guez, D
    Andrejak, M
    Araud, JM
    Aupy, JM
    Baclet, JL
    Baixas, JP
    Baud, J
    Billaut, P
    Bin, E
    Bioulac, B
    Blanche, M
    Blondel, D
    Bogetto, D
    Bonneau, D
    Bontemps, P
    Boucher, L
    Bourneuf, P
    Bouvet, P
    Boye, A
    Cabot, JM
    Cahoreau, R
    Calmet, G
    Campard, JC
    Cases, B
    Cassin, H
    Castellani, J
    Clerson, P
    Cognee, F
    CollRotger, J
    Constensoux, JP
    Copere, C
    Cozic, JA
    Dahan, G
    DalleRive, MC
    deSainteLorette, E
    Deltour, LC
    Drugeon, M
    Dubourg, D
    Dupont, S
    Cirica, NE
    ElSawy, A
    Eoche, R
    Etchegaray, G
    JOURNAL OF HYPERTENSION, 1995, 13 (12) : 1847 - 1851
  • [24] A promising choice in hypertension treatment: Fixed-dose combinations
    Xinhuan, Wan
    Panqin, Ma
    Xiangrong, Zhang
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 9 (01) : 1 - 7
  • [25] FIXED-DOSE COMBINATIONS IN THE TREATMENT OF HYPERTENSION IN THE RUSSIAN FEDERATION
    Vladimir, Kutsenko
    Balanova, Yulia
    Shalnova, Svetlana
    Imaeva, Asiia
    Kapustina, Anna
    Muromtseva, Galina
    Evstifeeva, Svetlana
    Karamnova, Natalya
    Maksimov, Sergey
    Yarovaya, Elena
    JOURNAL OF HYPERTENSION, 2021, 39 : E245 - E245
  • [26] Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension
    Chatzikyrkou, Christos
    Haller, Hermann
    Menne, Jan
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 63 - 76
  • [27] The Efficacy And The Safety Of A Fixed Dose Combination Of Amlodipine And Atorvastatin In Hypertensives With Dyslipidaemia
    Mukta, N. C.
    Prabha, A.
    Ashok, S. K.
    Nithyananda, C. K.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2010, 4 (05) : 3144 - 3149
  • [28] Efficacy of Fixed-Dose Combination Therapy in the Treatment of Patients with HypertensionFocus on Amlodipine/Valsartan
    Pedro Marques da Silva
    Clinical Drug Investigation, 2010, 30 : 625 - 641
  • [29] TRIPLE-DRUG, FIXED-DOSE COMBINATIONS FOR THE TREATMENT OF HYPERTENSION: FOCUS ON OLMESARTAN/AMLODIPINE/HYDROCHLOROTHIAZIDE COMBINATION
    Chrysant, S. G.
    DRUGS OF TODAY, 2011, 47 (03) : 197 - 206
  • [30] Evaluating the efficacy and safety of atorvastatin plus ezetimibe in a fixed-dose combination for the treatment of hypercholesterolemia
    Ma, Ya-Bin
    Chan, Paul
    Zhang, Yuzhen
    Tomlinson, Brian
    Liu, Zhongmin
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (08) : 917 - 928